If you hadnt noticed the clown ceo running biol into ground will soon be gone when his idiotic attempt to appeal the recent court ruling. In the filing made by Oracle recently clearly states that upon the dismissal of the Delaware Supreme appeal it will move forward with a proxy supported by 4 board members vs the 2 hold outs still in CEOs camp. That is why ceo is appealing cause the brd has basically turned on him. So unless he wins the appeal on 6/11 the new brd once the proxy voted occurs will seek his removal. Shortly there after im sure Oracle will move to address the funding issue here. 6m shares remain short so look out. Once this all occurs the stock wont be under $3.
Management is secondary to a robust product portfolio.
Sure management is a mess but the products here are not important and there is serious competition.
All this reaching for "new" markets that never materialize, all the patents that never produce a revenue stream, all the efforts to collaborate that never go anywhere, etc
This company is doomed to failure because they have nothing of importance to sell.
I say Good Luck to anyone brave enough to invest in BIOL but there is no "turnaround" story here, regardless of who's running the circus.
The reason The Waterlase is not selling is not because of lack of advertising or exposure.
It is not selling because it is expensive, inefficient and cannot compete with current methods used in dentistry.
It is simply a advertising gimmick to draw in fearful patients with claims of painless dentistry.
This is a dead horse that hopeful shareholders keep beating.
This will not turn around until patients go to their dentist and ask for Waterlase by name. The consumer needs to drive the business. If you asked 10 families if they knew about laser dentistry, 70% would say no. There is a fix, someone just needs to listen........